Analytical instrumentation market seen reaching $89.58 billion by 2030

The Business Research Company says the global analytical instrumentation market is set to grow from $61.45 billion in 2025 to $89.58 billion by 2030, driven by pharmaceutical R&D, lab automation and demand for precise testing tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The analytical instrumentation market underpins testing and measurement across pharmaceuticals, life sciences, food safety, environmental monitoring and forensic work. - Growth in this market signals higher demand for precision tools, software-enabled labs and compliance-focused testing. - The pharmaceutical sector is a major demand driver because drug development depends on accurate analysis, quality control and regulatory validation.

What happened: - The Business Research Company released its Analytical Instrumentation Market Report 2026, covering market size, trends and a global forecast for 2026-2035. - The market was valued at $61.45 billion in 2025. - The market is projected to reach $66.42 billion in 2026, implying 8.1% growth. - The market is forecast to reach $89.58 billion by 2030, at a 7.8% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Download a free sample of the report. - View the full analytical instrumentation market report.

The details: - Analytical instrumentation includes devices used to analyze the composition, structure and characteristics of materials or substances. - The tools provide detailed data on chemical, physical or biological samples. - The report ties historical growth to traditional laboratory instruments, limited software integration, expanding life sciences research, rising clinical and diagnostic testing, and broader use of spectroscopy and chromatography. - The forecast points to mass spectrometry, flow cytometry, sequencing, microarray technologies, laboratory automation, smart labs, software-enabled systems and multi-application platforms as key growth areas. - The report also highlights rising demand for calibration and maintenance services. - The report expects stronger adoption in food, environmental and forensic testing. - Regulatory compliance and quality assurance remain important market themes. - The analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis, and updated graphics and tables.

Between the lines: - Pharmaceutical R&D spending remains a central signal for instrument demand because the sector depends on exact measurements across discovery, development and manufacturing. - EFPIA reported in August 2025 that pharmaceutical companies invested about $60.38 billion (€52.4 billion) in R&D across Europe in 2023. - The regional outlook suggests mature demand in North America and faster expansion in Asia-Pacific as industrialization, healthcare infrastructure and research activity increase. - The shift toward software integration and lab automation shows the market is moving from standalone instruments toward connected, data-driven systems.

What's next: - The market is expected to keep expanding as laboratories adopt more automation, smarter workflows and higher-precision tools. - Growth should continue across clinical testing, life sciences research and regulated industrial applications. - Regional competition is likely to intensify as Asia-Pacific scales research and healthcare capacity.